Everest or bust: a cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas.
Buddha Basnyat(University of Washington), James A. Litch(Centers for Disease Control and Prevention), Joe Lemaster
PubMed
September 1, 1999
Cited by 101
Related Papers
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
|The Lancet|2022|16k
The 2018 Lake Louise Acute Mountain Sickness Score
|High Altitude Medicine & Biology|2018|562
Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events
|Nature Genetics|2015|489
Early prediction of preeclampsia in pregnancy with cell-free RNA
|Nature|2022|256